Literature DB >> 23926162

Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficile.

David S Rogers1, Sirisha Kundrapu, Venkata C K Sunkesula, Curtis J Donskey.   

Abstract

For long-term care and spinal cord injury patients, the sensitivity, specificity, and positive and negative predictive values of perirectal versus rectal cultures for detection of asymptomatic carriers of Clostridium difficile were 95%, 100%, 100%, and 97%, respectively. Perirectal cultures provide an accurate method to detect asymptomatic carriers of C. difficile.

Entities:  

Mesh：

Year:  2013        PMID： 23926162      PMCID： PMC3811660          DOI： 10.1128/JCM.01418-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract.

Authors:  Ebbing Lautenbach; Anthony D Harris; Eli N Perencevich; Irving Nachamkin; Pam Tolomeo; Joshua P Metlay
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

2.  Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci.

Authors:  J W Weinstein; S Tallapragada; P Farrel; L M Dembry
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

3.  Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.

Authors:  Scott R Curry; Carlene A Muto; Jessica L Schlackman; A William Pasculle; Kathleen A Shutt; Jane W Marsh; Lee H Harrison
Journal:  Clin Infect Dis       Date:  2013-07-23       Impact factor: 9.079

4.  Host and pathogen factors for Clostridium difficile infection and colonization.

Authors:  Vivian G Loo; Anne-Marie Bourgault; Louise Poirier; François Lamothe; Sophie Michaud; Nathalie Turgeon; Baldwin Toye; Axelle Beaudoin; Eric H Frost; Rodica Gilca; Paul Brassard; Nandini Dendukuri; Claire Béliveau; Matthew Oughton; Ivan Brukner; Andre Dascal
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245

5.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

6.  Epidemiology of clostridium difficile and vancomycin-resistant Enterococcus colonization in patients on a spinal cord injury unit.

Authors:  Donald M Dumford; Michelle Nerandzic; Shelley Chang; Mary Ann Richmond; Curtis Donskey
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

7.  Effective and reduced-cost modified selective medium for isolation of Clostridium difficile.

Authors:  Michelle M Nerandzic; Curtis J Donskey
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

8.  Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.

Authors:  Michelle M Riggs; Ajay K Sethi; Trina F Zabarsky; Elizabeth C Eckstein; Robin L P Jump; Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2007-09-04       Impact factor: 9.079

9.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.

Authors:  C R Clabots; S Johnson; M M Olson; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

10.  Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects.

Authors:  Stephen A Villano; Michael Seiberling; Walter Tatarowicz; Elizabeth Monnot-Chase; Dale N Gerding
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191
View more
  5 in total

1.  Validation of Active Surveillance Testing for Clostridium difficile Colonization Using the cobas Cdiff Test.

Authors:  Parul A Patel; Donna M Schora; Kamaljit Singh; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

2.  Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.

Authors:  Elisabeth M Terveer; Monique J T Crobach; Ingrid M J G Sanders; Margreet C Vos; Cees M Verduin; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2016-11-16       Impact factor: 5.948

3.  Genomic Determination of Relative Risks for Clostridioides difficile Infection From Asymptomatic Carriage in Intensive Care Unit Patients.

Authors:  Jay Worley; Mary L Delaney; Christopher K Cummins; Andrea DuBois; Michael Klompas; Lynn Bry
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

4.  Evaluation of the Use of Rectal Swabs for Laboratory Diagnosis of Clostridium difficile Infection.

Authors:  N Jazmati; E Kirpal; E Piepenbrock; Y Stelzer; M J G T Vehreschild; H Seifert
Journal:  J Clin Microbiol       Date:  2018-06-25       Impact factor: 5.948

Review 5.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.